A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients
Laquente, Berta, Lopez-Martin, Jose, Richards, Donald, Illerhaus, Gerald, Chang, David Z, Kim, George, Stella, Philip, Richel, Dirk, Szcylik, Cezary, Cascinu, Stefano, Frassineti, G L, Ciuleanu, Tudor, Hurt, Karla, Hynes, Scott, Lin, Ji, Lin, Aimee Bence, Von Hoff, Daniel, Calvo, Emiliano
Published in BMC cancer (15.02.2017)
Published in BMC cancer (15.02.2017)
Get full text
Journal Article
Phase III trial of dovitinib (TKI258) versus sorafenib in patients with metastatic renal cell carcinoma after failure of anti-angiogenic (VEGF-targeted and mTOR inhibitor) therapies
Motzer, Robert John, Porta, Camillo, Bjarnason, Georg A., Szcylik, Cezary, Rha, Sun Young, Esteban, Emilio, De Giorgi, Ugo, MacKenzie, Mary J., Mainwaring, Paul N., North, Scott, Sabbatini, Roberto, Bodrogi, Istvan, Kabbinavar, Fairooz, Carteni, Giacomo, Sternberg, Cora N., Vogelzang, Nicholas J., Shi, Michael, Urbanowitz, Gladys, Escudier, Bernard J.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article